Post by CTIN (Clinical Trials Information Network)

6,728 followers

Our new LinkedIn newsletter series explores how European clinical trial markets differ beyond headline numbers. In each edition, we compare selected countries across key market signals - from trial activity and therapeutic focus to research capacity and ecosystem dynamics. šŸ‘‰ This is only a snapshot. The full version is available for free via the link in the comments. šŸŒ We are CTIN ā†’ Clinical Trials Information Network š–šž š›š«š¢šš šž š„š®š«šØš©šžā€™š¬ šœš„š¢š§š¢šœššš„ š«šžš¬šžššš«šœš” šžšœšØš¬š²š¬š­šžš¦ šŸ” Follow for clinical research market insights šŸ¤ Share to support our mission #ClinicalResearch #Insights Cellectis Corteria Pharmaceuticals NOVADIP Biosciences S.A. Greater Paris University Hospitals - AP-HP Unicancer Research Glaxosmithkline (GSK) Chair in Optimal Chronic Disease Management in Primary Care Boehringer Ingelheim

Post content